-
公开(公告)号:US20220242910A1
公开(公告)日:2022-08-04
申请号:US17579463
申请日:2022-01-19
发明人: Jae Young SEONG , Jong-Ik HWANG , Dong-Hoon KIM , Gi Hoon SON , Yoo-Na LEE , Seongsik YUN , Arfaxad REYES-ALCARAZ
IPC分类号: C07K7/08 , A61P25/28 , A61P25/30 , A61P25/22 , A61P25/18 , A61P25/24 , A61P25/06 , A61K9/00 , A61K9/19
摘要: The present invention relates to spexin-based agonists specific for galanin receptor type 2 and use thereof. More specifically, the present invention provides peptide-based agonists with high specificity for galanin receptor type 2 and improved stability. The peptide-based agonists are involved in the regulation of in vivo physiological functions, such as food intake, anxiety, emotion, and addiction, for which galanin receptors type 2 is responsible, to effectively suppress appetite, help recover from anxiety disorder, and reduce pleasure addiction. Therefore, the peptide-based agonists can be used to prevent or treat galanin receptor type 2-mediated diseases.
-
公开(公告)号:US20200010509A1
公开(公告)日:2020-01-09
申请号:US16511976
申请日:2019-07-15
发明人: Jae Young SEONG , Jong-Ik HWANG , Dong-Hoon KIM , Gi Hoon SON , Yoo-Na LEE , Seongsik YUN , Arfaxad REYES-ALCARAZ
IPC分类号: C07K7/08 , A61K9/19 , A61K9/00 , A61P25/06 , A61P25/24 , A61P25/18 , A61P25/22 , A61P25/30 , A61P25/28
摘要: The present invention relates to spexin-based agonists specific for galanin receptor type 2 and use thereof. More specifically, the present invention provides peptide-based agonists with high specificity for galanin receptor type 2 and improved stability. The peptide-based agonists are involved in the regulation of in vivo physiological functions, such as food intake, anxiety, emotion, and addiction, for which galanin receptors type 2 is responsible, to effectively suppress appetite, help recover from anxiety disorder, and reduce pleasure addiction. Therefore, the peptide-based agonists can be used to prevent or treat galanin receptor type 2-mediated diseases.
-